Onward Medical N.V. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 0.9 million compared to EUR 1 million a year ago. Net loss was EUR 19.2 million compared to EUR 16 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.71 EUR | +0.43% | -6.18% | +51.94% |
Apr. 25 | Onward Medical N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 02 | Onward Medical Seeks US FDA Nod to Market Spinal Cord Stimulation Therapy | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+51.94% | 173M | |
+73.30% | 12.38B | |
-19.52% | 7.92B | |
+15.74% | 7.2B | |
+6.78% | 5.84B | |
+7.49% | 5.07B | |
+23.97% | 4.53B | |
-21.67% | 3.88B | |
-40.53% | 2.23B | |
+1.24% | 2.02B |
- Stock Market
- Equities
- ONWD Stock
- News Onward Medical N.V.
- Onward Medical N.V. Reports Earnings Results for the Half Year Ended June 30, 2023